The EU should fund studies into the medical use of cannabis and EU-based doctors should be allowed to prescribe cannabis-based medicines, the European Parliament has said.
A resolution adopted by the Parliament on 13 February calls for research on cannabis-based medicines to be included in the EU’s next R&D programme Horizon Europe. MEPs stated that there is some evidence that cannabinoids can help alleviate chronic pain, chemotherapy-induced nausea and vomiting and some symptoms of multiple sclerosis, as well as anxiety disorders, post-traumatic stress disorder, depression and other conditions.
However, “research on the potential benefits of medicines derived from cannabis and on cannabis in general has been underfunded”, the resolution says. Furthermore, EU member states “differ widely in their approach to cannabis legislation” while globally, policies around using cannabis for medical purposes is evolving.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.